Braingineering Technologies (BTECH)
Owner/Developer: Braingineering Technologies (BTECH)
With a new high-tech Brain-on-a-Chip technology Braingineering Technologies (BTech), a spin-off of the Luxembourg Centre for Systems Biomedicine (LCSB), supports pharmaceutical companies in the drug discovery and pre-clinical testing phase to identify compounds that are promising to pass the clinical trials by providing relevant in vitro models. BTech focuses on neurodegenerative diseases: Parkinson’s disease, Alzheimer’s disease, and further diseases. The advantages to 2D in vitro and animal testing is that the 3D Brain-on-a-Chip technology mimics human neurodegenerative diseases more adequately, it enables medium throughput screening, it reduces animal testing and it ensues low costs for the customer due to less media.
|Channel:||Website - Professional online network|
|Audience:||Scientists - Industry|
|User access:||Open access|
|Updating frequency:||Frequently updated|
|Relevance:||Replacement - Reduction|
|Purpose:||Production and quality control - Fundamental studies - Method development - Efficacy testing - Toxicological and safety evaluation|
|Technology/Tools:||Alternative test methods (in vitro) - Tissue engineering|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.